GC19110
COH29
Also known as N-[4-(3,4-dihydroxyphenyl)-5-phenyl-1,3-thiazol-2-yl]-3,4-dihydroxybenzamide
COH29 is a potent ribonucleotide reductase (RNR) inhibitor with anticancer activity
ChemicalCAS1190932-38-7MW420.44FormulaC22H16N2O5S
- CAS number
- 1190932-38-7
- Molecular weight
- 420.44
- Formula
- C22H16N2O5S
- Solubility
- DMSO ： ≥ 31 mg/mL (73·73 mM)
- InChIKey
- LGGDLPSXAGQFSG-UHFFFAOYSA-N
- Catalogue number
- GC19110
- Brand
- GLPBIO
Computed properties PubChem CID 44253415 · XLogP 4 · TPSA 151 Ų · H-bond donors 5
- XLogP
- 4
- TPSA
- 151 Ų
- H-bond donors
- 5
- H-bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 30
SMILES C1=CC=C(C=C1)C2=C(N=C(S2)NC(=O)C3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)O)O
Computed descriptors from PubChem (CID 44253415), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il